Bio-Rad Laboratories
(BIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 0 | 414,694 | 409,144 | 0 |
| Accounts receivable | 527,132 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -453,266 | N/A | N/A | N/A | N/A |
| Other Working Capital | 44,981 | 0 | -381,489 | -354,641 | 0 |
| Other Operating Activity | -73,866 | 27,330 | -12,096 | -21,350 | 38,232 |
| Operating Cash Flow | $44,981 | $27,330 | $21,109 | $33,153 | $38,232 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 4,384 | N/A | N/A | N/A | N/A |
| PPE Investments | -27,275 | -21,170 | -23,571 | -15,235 | -12,307 |
| Net Acquisitions | -202,828 | 0 | -31,238 | -1,290 | -829 |
| Other Investing Activity | 2,401 | -4,080 | -1,116 | 1,681 | -777 |
| Investing Cash Flow | $-223,318 | $-25,250 | $-55,925 | $-14,844 | $-13,913 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 353,108 | N/A | N/A | N/A | N/A |
| Debt Repayment | -151,788 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 1,665 | N/A | N/A | N/A | N/A |
| Common Stock Repurchased | -2,233 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -18,501 | -900 | 33,518 | -25,167 | -13,105 |
| Financing Cash Flow | $182,251 | $-900 | $33,518 | $-25,167 | $-13,105 |
| Exchange Rate Effect | 3,092 | -1,930 | 2,751 | 1,474 | -191 |
| Beginning Cash Position | 10,081 | 10,840 | 9,390 | 14,774 | 3,751 |
| End Cash Position | 17,087 | 10,080 | 10,843 | 9,390 | 14,774 |
| Net Cash Flow | $7,006 | $-760 | $1,453 | $-5,384 | $11,023 |
| Free Cash Flow | |||||
| Operating Cash Flow | 44,981 | 27,330 | 21,109 | 33,153 | 38,232 |
| Capital Expenditure | -27,275 | N/A | N/A | N/A | N/A |
| Free Cash Flow | 17,706 | 27,330 | 21,109 | 33,153 | 38,232 |